Effective salvage treatment of recurrent Ewing sarcoma utilizing chemotherapy and zoledronic acid.
Siddiqui
Tariq
T
Division of Hematology Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL 32610-0278, USA. siddit@medicine.ufl.edu
Marsh
Robert de Wilton
Rde W
Allegra
Carmen
C
Whittaker
Denise
D
Scarborough
Mark
M
Gibbs
Parker
P
Zlotecki
Robert
R
Reith
John David
JD
Drane
Walter
W
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004164:Diphosphonates / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000188:drug therapy*; D012074:Remission Induction; D016879:Salvage Therapy; D012512:Sarcoma, Ewing / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid